Thymidine kinase and mtDNA depletion in human cardiomyopathy: Epigenetic and translational evidence for energy starvation

Physiological Genomics

Volumn 45, Issue 14, 2013, Pages 590-596

  Koczor, Christopher A ^a   Torres, Rebecca A ^a   Fields, Earl J ^a   Boyd, Amy ^a   He, Stanley ^a   Patel, Nilamkumar ^b   Lee, Eva K ^c   Samarel, Allen M ^b   Lewis, William ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Dilated cardiomyopathy; Mitochondria; Mitochondrial DNA; Thymidine kinase

Indexed keywords

CELL NUCLEUS DNA; MITOCHONDRIAL DNA; THYMIDINE KINASE; THYMIDINE KINASE 1;

ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DNA METHYLATION; DNA REPLICATION; ENERGY CONSERVATION; ENZYME ACTIVITY; EPIGENETICS; GENE; GENE EXPRESSION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART RIGHT VENTRICLE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MITOCHONDRIAL DNA DEPLETION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TK 1 GENE; TRANSLATIONAL RESEARCH;

DILATED CARDIOMYOPATHY; MITOCHONDRIA; MITOCHONDRIAL DNA; THYMIDINE KINASE;

BLOTTING, WESTERN; CARDIOMYOPATHIES; DNA METHYLATION; DNA, MITOCHONDRIAL; EPIGENESIS, GENETIC; HUMANS; MIDDLE AGED; THYMIDINE KINASE;

EID: 84880269856     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00014.2013     Document Type: Article

References (46)

1. Ahmad F, Seidman JG, Seidman CE. The genetic basis for cardiac remodeling. Ann Rev Genom Hum Genet 6: 185-216, 2005.
2. Arbustini E, Diegoli M, Fasani R, Grasso M, Morbini P, Banchieri N, Bellini O, Dal Bello B, Pilotto A, Magrini G, Campana C, Fortina P, Gavazzi A, Narula J, Vigano M. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 153: 1501-1510, 1998.
3. Arner ES, Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol Ther 67: 155-186, 1995.
4. Baandrup U, Olsen EG. Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. I. Morphological and morphometric aspects. Br Heart J 45: 475-486, 1981.
5. Bohlega S, Tanji K, Santorelli FM, Hirano M, al-Jishi A, DiMauro S. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 46: 1329-1334, 1996.
6. Chien KR, Olson EN. Converging pathways and principles in heart development and disease: CV@CSH. Cell 110: 153-162, 2002.
7. Dorado B, Area E, Akman HO, Hirano M. Onset and organ specificity of Tk2 deficiency depends on Tk1 down-regulation and transcriptional compensation. Hum Mol Genet 20: 155-164, 2011.
8. Elpeleg O. Inherited mitochondrial DNA depletion. Pediatr Res 54: 153-159, 2003.
9. Franzolin E, Rampazzo C, Perez-Perez MJ, Hernandez AI, Balzarini J, Bianchi V. Bromovinyl-deoxyuridine: a selective substrate for mitochondrial thymidine kinase in cell extracts. Biochem Biophys Res Commun 344: 30-36, 2006.
10. Hosseini SH, Kohler JJ, Haase CP, Tioleco N, Stuart T, Keebaugh E, Ludaway T, Russ R, Green E, Long R, Wang L, Eriksson S, Lewis W. Targeted transgenic overexpression of mitochondrial thymidine kinase (TK2) alters mitochondrial DNA (mtDNA) and mitochondrial polypeptide abundance: transgenic TK2, mtDNA, and antiretrovirals. Am J Pathol 170: 865-874, 2007.
11. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucl Acid Res 37: 1-13, 2009.
12. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protocol 4: 44-57, 2009.
13. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95: 135-145, 2004.
14. Jessup M, Brozena S. Heart failure. N Engl J Med 348: 2007-2018, 2003.
15. Johansson M, Karlsson A. Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2. J Biol Chem 272: 8454-8458, 1997.
16. Jullig M, Hickey AJ, Chai CC, Skea GL, Middleditch MJ, Costa S, Choong SY, Philips AR, Cooper GJ. Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats. Proteomics 8: 2556-2572, 2008.
17. Karamanlidis G, Nascimben L, Couper GS, Shekar PS, del Monte F, Tian R. Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res 106: 1541-1548, 2010.
18. Koczor CA, Lee EK, Torres RA, Boyd A, Vega JD, Uppal U, Yuan F, Fields EJ, Samarel AM, Lewis W. Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis. Physiol Genomics doi: 10.1152/physiolgenomics.00013.2013.
19. Kohl NE, Emini EA, Schleif WA, Davis LJ, Heimbach JC, Dixon RA, Scolnick EM, Sigal IS. Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci USA 85: 4686-4690, 1988.
20. Kohler JJ, Cucoranu I, Fields E, Green E, He S, Hoying A, Russ R, Abuin A, Johnson D, Hosseini SH, Raper CM, Lewis W. Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy. Lab Invest 89: 782-790, 2009.
21. Kohler JJ, Hosseini SH, Cucoranu I, Hoying-Brandt A, Green E, Johnson D, Wittich B, Srivastava J, Ivey K, Fields E, Russ R, Raper CM, Santoianni R, Lewis W. Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside phosphorylation. Lab Invest 89: 122-130, 2009.
22. Kohler JJ, Hosseini SH, Green E, Hoying-Brandt A, Cucoranu I, Haase CP, Russ R, Srivastava J, Ivey K, Ludaway T, Kapoor V, Abuin A, Shapoval A, Santoianni R, Saada A, Elpeleg O, Lewis W. Cardiac-targeted transgenic mutant mitochondrial enzymes: mtDNA defects, antiretroviral toxicity and cardiomyopathy. Cardiovasc Toxicol 8: 57-69, 2008.
23. Kohler JJ, Hosseini SH, Lewis W. Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathy. Chem Res Toxicol 21: 990-996, 2008.
24. Lee EK. Large-scale optimization-based classification models in medicine and biology. Ann Biomed Eng 35: 1095-1109, 2007.
25. Lemieux H, Semsroth S, Antretter H, Hofer D, Gnaiger E. Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. Int J Biochem Cell Biol 43: 1729-1738, 2011.
26. Lewis W, Day BJ, Kohler JJ, Hosseini SH, Chan SS, Green EC, Haase CP, Keebaugh ES, Long R, Ludaway T, Russ R, Steltzer J, Tioleco N, Santoianni R, Copeland WC. Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase gamma. Lab Invest 87: 326-335, 2007.
27. Marin-Garcia J, Goldenthal MJ. Mitochondrial centrality in heart failure. Heart Fail Rev 13: 137-150, 2008.
28. Mestroni L, Gilbert EM, Lowes BD, Bristow MR. Dilated cardiomyopathy. In: Hurst's The Heart, edited by Fuster V, O'Rourke RA, Poole- Wilson, P, Walsh, RA. New York: McGraw Hill, 2008, p. 803-821.
29. Munch-Petersen B, Cloos L, Tyrsted G, Eriksson S. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J Biol Chem 266: 9032-9038, 1991.
30. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med 356: 1140-1151, 2007.
31. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283: 689-692, 1999.
32. Palmieri L, Alberio S, Pisano I, Lodi T, Meznaric-Petrusa M, Zidar J, Santoro A, Scarcia P, Fontanesi F, Lamantea E, Ferrero I, Zeviani M. Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Hum Mol Genet 14: 3079-3088, 2005.
33. Perez-Perez MJ, Hernandez AI, Priego EM, Rodriguez-Barrios F, Gago F, Camarasa MJ, Balzarini J. Mitochondrial thymidine kinase inhibitors. Curr Topic Med Chem 5: 1205-1219, 2005.
34. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, Pirani A, Gernert K, Deng J, Marzolf B, Kennedy K, Wu H, Bennouna S, Oluoch H, Miller J, Vencio RZ, Mulligan M, Aderem A, Ahmed R, Pulendran B. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10: 116-125, 2009.
35. Rosca MG, Hoppel CL. New aspects of impaired mitochondrial function in heart failure. J Bioenerg Biomembr 41: 107-112, 2009.
36. Saada-Reisch A. Deoxyribonucleoside kinases in mitochondrial DNA depletion. Nucleoside Nucleotide Nucl Acid 23: 1205-1215, 2004.
37. Saada A. Deoxyribonucleotides and disorders of mitochondrial DNA integrity. DNA Cell Biol 23: 797-806, 2004.
38. Saada A, Ben-Shalom E, Zyslin R, Miller C, Mandel H, Elpeleg O. Mitochondrial deoxyribonucleoside triphosphate pools in thymidine kinase 2 deficiency. Biochem Biophys Res Commun 310: 963-966, 2003.
39. Saada A, Shaag A, Elpeleg O. mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency. Mol Genet Metab 79: 1-5, 2003.
40. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29: 342-344, 2001.
41. Samarel A, Walsh RW. Molecular and cellular biology of the normal, hypertrophied and failing heart. In: Hurst's The Heart, edited by Fuster V, O'Rourke RA, Poole-Wilson, P, Walsh, RA. New York: McGraw Hill, 2008, p. 123-134.
42. Van Rompay AR, Johansson M, Karlsson A. Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases. Pharmacol Ther 100: 119-139, 2003.
43. Ventura-Clapier R, Garnier A, Veksler V, Joubert F. Bioenergetics of the failing heart. Biochim Biophys Acta 1813: 1360-1372, 2011.
44. Villarroya J, Dorado B, Vila MR, Garcia-Arumi E, Domingo P, Giralt M, Hirano M, Villarroya F. Thymidine kinase 2 deficiency-induced mitochondrial DNA depletion causes abnormal development of adipose tissues and adipokine levels in mice. PLoS One 6: e29691, 2011.
45. Wang L, Eriksson S. Tissue specific distribution of pyrimidine deoxynucleoside salvage enzymes shed light on the mechanism of mitochondrial DNA depletion. Nucleoside Nucleotide Nucl Acid 29: 400-403, 2010.
46. Wang L, Sun R, Eriksson S. The kinetic effects on thymidine kinase 2 by enzyme-bound dTTP may explain the mitochondrial side effects of antiviral thymidine analogs. Antimicrob Agent Chemother 55: 2552-2558, 2011.